17
Participants
Start Date
December 2, 2022
Primary Completion Date
April 14, 2025
Study Completion Date
April 14, 2025
Emraclidine
Oral tablets
Placebo
Oral tablets
Staten Island, New York, Staten Island
Decatur, Georgia, Decatur
Hialeah, Florida, Hialeah
North Canton, Ohio, North Canton
Farmington Hills, Michigan, Farmington Hills
Overland Park, Kansas, Overland Park
Cypress, California, Cypress
San Diego, California, San Diego
Honolulu, Hawaii, Honolulu
Marlton, New Jersey, Marlton
Princeton, New Jersey, Princeton
Lead Sponsor
AbbVie
INDUSTRY